Novo Nordisk A/S (NVO)
46.62
-0.88
(-1.86%)
USD |
NYSE |
Sep 04, 16:00
46.53
-0.10
(-0.20%)
After-Hours: 18:37
Novo Nordisk Cash and Short Term Investments (Annual) : 4.240B for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 4.240B |
| December 31, 2024 | 3.653B |
| December 31, 2023 | 4.480B |
| December 31, 2022 | 3.383B |
| December 31, 2021 | 2.673B |
| December 31, 2020 | 2.097B |
| December 31, 2019 | 2.325B |
| December 31, 2018 | 2.396B |
| December 31, 2017 | 3.412B |
| December 31, 2016 | 3.011B |
| December 31, 2015 | 3.023B |
| December 31, 2014 | 2.589B |
| December 31, 2013 | 2.953B |
| December 31, 2012 | 3.010B |
| December 31, 2011 | 3.065B |
| December 31, 2010 | 2.890B |
| December 31, 2009 | 2.473B |
| December 31, 2008 | 1.897B |
| December 31, 2007 | 1.447B |
| December 31, 2006 | 902.69M |
| December 31, 2005 | 794.66M |
| December 31, 2004 | 723.43M |
| December 31, 2003 | 523.45M |
| Date | Value |
|---|---|
| December 31, 2002 | 245.54M |
| December 31, 2001 | 366.69M |
| December 31, 2000 | 483.65M |
| December 31, 1999 | 608.00M |
| December 31, 1998 | 426.90M |
| December 31, 1997 | 590.30M |
| December 31, 1996 | 474.66M |
| December 31, 1995 | 672.50M |
| December 31, 1994 | 667.98M |
| December 31, 1993 | 524.63M |
| December 31, 1992 | 623.29M |
| December 31, 1991 | 739.57M |
| December 31, 1990 | 514.85M |
| December 31, 1989 | 447.28M |
| December 31, 1988 | 365.59M |
| December 31, 1987 | 334.00M |
| December 31, 1986 | 271.22M |
| December 31, 1985 | 234.86M |
| December 31, 1984 | 189.65M |
| December 31, 1983 | 178.78M |
| December 31, 1982 | 86.25M |
| December 31, 1981 | 108.06M |
| December 31, 1980 | 42.25M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| AstraZeneca PLC | 5.741B |
| Johnson & Johnson | 20.10B |
| Eli Lilly & Co. | 7.268B |
| Merck & Co., Inc. | 14.69B |
| Novartis AG | 11.59B |